
    
      Objective of this pivotal study was to assess the bioequivalence between Test Product:
      Indomethacin Extended-Release Capsules USP 75 mg of Ipca Laboratories Limited, India and the
      corresponding Reference Product: Indomethacin Extended-Release Capsules USP 75 mg of Epic
      Pharma, USA, under fed condition in normal, healthy, adult, male and female human subjects in
      a randomized crossover study.

      The study was conducted with 32 healthy adult subjects. In each study period, a single 75 mg
      dose of either test or reference was administered to the subjects as per the randomization
      schedule in each study period with about 240 mL of water at ambient temperature in sitting
      position.

      The duration of the clinical phase was approximately 10 days including washout period of at
      least 7 days between administrations of study drug in each study period.
    
  